Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 28;13:825901. doi: 10.3389/fgene.2022.825901

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Deng, Xiong, He, Bin, Song, Li and Qin.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Prognostic values of MCTS1 expression in patients with breast cancer evaluated by the Kaplan-Meier method in different subgroups. (A–J) OS survival curves of T1 and T2, N2 and N3, M0, stage II and III, age >60 years, IDC, ER positive, PR positive, HER2 positive, and Luminal B subgroups between high- and low-MCTS1 patients with breast cancer. (K–T) DSS survival curves of T1 and T2, N2 and N3, M0, stage II and III, age >60 years, IDC, ER positive, PR positive, HER2 positive, and Luminal B subgroups between high- and low-MCTS1 patients with breast cancer. OS, overall survival; DSS, disease-specific survival; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; LumB, Luminal B; IDC, infiltrating ductal carcinoma.